The recent use of Swietenia mahagoni (L.) Jacq. as antidiabetes type 2 phytomedicine: A systematic review
Sukardiman Sukardiman, Martha Ervina
Abstract
BACKGROUND: ) has been used as traditional medicine in Indonesia and India, though most popular utilized as timber wood. METHODS: mahagony, diabetes, and diabetes plants. RESULTS: consist of the phenolics (flavonoids (swietemacrophyllanin, catechins and epichatechins) and tannins), triterpenoids and tetranortriterpenoids (limonoids: mahonin, secomahoganin, swietmanins, swiemahogins, swietenine and swietenolide), saponins and alkaloids which are known as anti-diabetic bioactive principles. CONCLUSION: was potentially used and developed as an antidiabetes source. To use it as an antidiabetic further, more extensive clinical trials and biomarkers of active compounds determination are needed.
Topics & Concepts
PhytomedicineBiologyTraditional medicineMedicinePhytochemical compounds biological activitiesPineapple and bromelain studiesSynthesis of Organic Compounds